Palliative Systemic Therapy in Advanced Thymic Epithelial Tumors in 2026—A Narrative Review
Felix Carl Saalfeld, Tobias R. Overbeck
0 citationsCancers
Tobias R. Overbeck
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
119Publications signalées
3908Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Lung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies
Publications récentes
PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
N. Frost, Maria Joosten, Jannik Franzen, Marcel Wiesweg et autres
4 citationsAnnals of Oncology
Proteasome inhibition as a potential therapeutic target in thymic cancer
Satoru Okada, Louisa Benter, Leon Schrell, Denise Müller et autres
1 citationCell Death and Disease
Delay of Systemic Therapy Confers a Survival Benefit in Patients with Stage IV Non-Small-Cell Lung Cancer
Rike Geiken-Weinstock, Frank Griesinger, Michael Metz, Ralf G. Meyer et autres
0 citationsCancers
Efficacy of targeted therapy in lung cancer with rare ALK fusions
Marie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, Diego Kauffmann‐Guerrero et autres
0 citationsResearch Square
Impact of radiation dose on immune cells (EDIC) on oncologic outcome in small cell lung cancer (SCLC)
Hannah Sophie Penzl, David Alexander Ziegler, Markus Schirmer, Jona Bensberg et autres
4 citationsRadiotherapy and Oncology
1879P Retrospective multicenter analysis of real-world clinical data in patients with PD-L1-negative stage IV non-small cell lung cancer in Germany: “REMARCS-PD-L1-neG
C Kropf-Sanchen, P. Christopoulos, Marcel Wiesweg, J. Roeper et autres
0 citationsAnnals of Oncology
Delay of systemic therapy confers a survival benefit in patients with stage IV non-small cell lung cancer
Rike Geiken-Weinstock, Frank Griesinger, Michael Metz, Ralf G. Meyer et autres
0 citationsResearch Square
Rare ALK: Clinical characteristics and efficacy of targeted therapy in NSCLC with ALK fusions other than EML4::ALK.
Felix Carl Saalfeld, Marie-Elisabeth Leßmann, Lea Ruge, Oliver Illini et autres
0 citationsJournal of Clinical Oncology
Thymome und Thymuskarzinome: Therapielandschaft von thymischen epithelialen Tumoren in Deutschland
Tobias R. Overbeck, Felix Carl Saalfeld
0 citationsTrillium Krebsmedizin
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Non-Targeted therapy in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Thymic Epithelial Tumors
Marie-Elisabeth Leßmann, Christine Sibbert, Lea Reitnauer, Sophie Heinzen et autres
0 citationsOncology Research and Treatment
Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT
Julian Muster, Niklas Josua Alt, Marcus Edelmann, Mahalia Zoe Anczykowski et autres
0 citationsStrahlentherapie und Onkologie
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.